Biomolecular drug delivery engineers create innovative systems that transport delicate biomolecules—such as proteins, peptides, and nucleic acids—to targeted tissues or cells efficiently and safely. These biomolecules often face significant challenges, including instability, enzymatic degradation, and poor cellular uptake, which can hinder their therapeutic effectiveness. To overcome these obstacles, these engineers design and optimize delivery platforms like nanoparticles, liposomes, and polymeric carriers that protect the biomolecules, control their release, and enhance targeting capabilities. Their work is vital in advancing treatments for complex diseases such as cancer, genetic disorders, and autoimmune conditions, where precision and efficacy are critical.
Biomolecular drug delivery engineers perform extensive evaluations to ensure biocompatibility, optimize pharmacokinetics, and minimize side effects. They collaborate closely with molecular biologists, pharmacologists, and clinicians to translate laboratory discoveries into effective clinical therapies. As personalized medicine and biotechnology continue to grow, these engineers play a pivotal role in tailoring therapies to individual patient needs and overcoming biological barriers. Their ongoing innovations are essential to expanding the therapeutic potential of biomolecules and improving patient outcomes. Through integrating engineering principles with biological insights, they develop solutions that are both scientifically advanced and clinically practical. Ultimately, biomolecular drug delivery engineers help bridge the gap between scientific research and practical medicine, driving forward the future of precision therapeutics.
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : From marker to mechanism: Ligand discovery enables functional analysis of OR51E1, an ectopic olfactory receptor, in prostate cancer
Vladlen Slepak, University of Miami School of Medicine, United States
Title : Hydrogen sulfide in sepsis: From bench to bedside
Madhav Bhatia, University of Otago, New Zealand
Title : Tailored cellular environments to enable drug design
Lan Wang, Paretor LLC, United States
Title : Development of novel drug delivery pathways enabled by perillyl alcohol (NEO100), A monoterpene with multifaceted biomedical applications
Axel H Schonthal, University of Southern California, United States
Title : A NAMs-compatible mechanopharmacological model of drug penetration in the urinary bladder
Kunal Sharma, Swisss Federal Institute of Technology Lausanne, Switzerland
Title : Application of quality by design for pulmonary liposomes: Preliminary study to nano in-microparticle
Lucas Amaral Machado, University of Sao Paulo State – UNESP, Brazil
Title : Integrated Raman, SERS and computational approaches for the study of bioactive molecules in pharmaceutical chemistry
Maria Cristina Gamberini, University of Modena and Reggio Emilia, Italy
Title : The impact of metal-decorated polymeric nanodots on proton relaxivity
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, University of Alberta, Canada